Orionis Biosciences
Technologiepark 94
9052 Zwijnaarde
BE
Orionis Biosciences
Foundation date
01/09/2015
Sector
#Biotechnology - TherapeuticsSubsector
Therapeutic areas
We are an early stage drug discovery and development biotechnology company fueled by a suite of disruptive technologies to advance innovative medicines for the treatment of diseases with high unmet medical need – with an initial internal focus in oncology and immunotherapies.
Upcoming events
All events-
1605 '24
Knowledge for Growth 2024
Event by: flanders.bio -
1505 '24
State of the Union by VIB & flanders.bio
Event by: flanders.bio & VIB -
2105 '24
IOT Solutions World Congress 2024
Event by: Fira Barcelona
Latest news
More news-
V-Bio Ventures leads €20 million Series A financing of Precision oncology company Flindr Therapeutics to advance first-in-class small molecule inhibitors
Wednesday April 24th 2024
Read more
-
Labconsort and NEKTARI join forces for a more sustainable and social industry
Saturday April 20th 2024
Read more
-
BIO INX Complements Advisory Board with Distinguished Industry Leaders
Thursday April 18th 2024
Read more
Jobs
More jobs-
-
24/04/24
Brussels
Laboratory Technician / Scientific Collaborator in Protein Biochemistry
Permanent
VIB -
23/04/24
Brussels
PhD Student Position: Fluorescent Biosensors in Neurodegenerative Diseases
Permanent
VIB
More info?
Ellen Telleir
Communication Coordinator